Bringing the fundamentals into focus…
Back to Teladoc Health, Inc.
How Teladoc Health, Inc. stacks up
TDOC · against 445 other Healthcare companies of similar size
Valuation
41/ 100
Below the middle of the pack.
Ranked #270 of 446 · scores higher than 39% of peers
Bars: peers in each 10-point band of the valuation score43 peers with a valuation score of 40–49, including TDOC · Click a bar to see the companies
Why valuation scores 41?
Weighted metrics compared with all Healthcare companies.A mix: stronger free cash flow yield, but weaker earnings yield than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -11.1% vs peer median 1.5%
- EBITDA yield is close to the peer norm. EBITDA yield: 3.4% vs peer median 4.0%
- more free cash flow for the price paid: stronger than 89% of peers. Free cash flow yield: 7.3% vs peer median 0.0%
Metric by metric
Position: dot = TDOC, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | TDOC | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 434 reported | -11.1% | 1.5% | 14% | 30% | |
| EBITDA yieldHigher is better · 447 reported | 3.4% | 4.3% | 46% | 50% | |
| Free cash flow yieldHigher is better · 203 reported | 7.3% | -0.5% | 86% | 20% | |
| Book yieldHigher is better · 436 reported | 81.1% | 37.5% | 85% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around TDOCScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score